The goal of this study was to develop a simplified radiological score that could assess clinical disease severity in bronchiectasis.
High-resolution CT (HRCT) scan of the thorax remains the imaging gold standard for diagnosing bronchiectasis; for diagnosis, patients should have bronchial dilatation at least greater than the adjacent pulmonary artery. [1] [2] [3] [4] [5] In 1991, Bhalla et al 6 published a detailed scoring system to quantify structural lung abnormalities in patients with cystic fibrosis using thin-section CT scans. Subsequent to that study, Reiff et al 7 developed a scoring system that described the site, type, and extent of bronchiectasis, and since then, the "modified Reiff score" has been frequently used in studies. The Bronchiectasis Severity Index (BSI) and the FACED score were devised by using several clinical parameters, including number of lobes affected by bronchiectasis on CT scanning, to predict severity and prognosis in bronchiectasis. 8, 9 However, both studies included a heterogeneous population with bronchiectasis and a variable smoking history. In addition, the radiology scoring in both scores only took into account the number of lobes affected by bronchiectasis 9 and the presence of cystic bronchiectasis. 8 Both these scores are easy to use but are multidimensional.
Hence, the role of CT imaging in defining bronchiectasis phenotypes in addition to conventional characterization must still be fully determined. CT scanning as a phenotypical marker of airway disease is not yet established, and no studies have stratified for the etiology of bronchiectasis. 10 The aim of the present study was to develop a simple CT score that could assess clinical disease severity in idiopathic and postinfective bronchiectasis in a cohort with limited smoking history, using multivariable models.
Patients and Methods

Study Design
A prospective study was conducted between 2006 and 2013 at the Royal Infirmary of Edinburgh, United Kingdom. All new adult patients attending the bronchiectasis clinic routinely had a noncontrast HRCT scan acquired with 1-mm slices as a single breath hold on a 64 multislice CT scanner (Toshiba Medical Systems). Clinical parameters recorded at the time of the CT scan were as follows: spirometry; degree of sputum purulence (mucoid ¼ 1; mucopurulent ¼ 2; and purulent $ 3)
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; qualitative sputum microbiology (baseline, 6 and 12 months following); exacerbations requiring antibiotics; and hospital admissions for bronchiectasis exacerbations in the following year.
Neutrophil elastase activity was measured in sputum when available.
Ethical Approval
Caldicott approval was given for conducting the study.
Imaging
Across all centers, CT scans were obtained by using a 64-slice multiple detector CT scanner (Toshiba/ Siemens/Philips) or a 4-slice multiple detector CT scanner (Toshiba/Siemens/Philips). All scans were reconstructed by using a high spatial frequency, B70 kernel. All patients were scanned from lung apices to bases, supine, at full inspiration, with 1.0-mm section thicknesses at either 1-or 10-mm intervals using a peak voltage of 120 kVp with tube current modulation (range: 30-140 mA). Images were viewed at window settings optimized for the assessment of the lung parenchyma (width: 1,500 Hounsfield units; level: -500 Hounsfield units).
Across centers, all images were reviewed by a consultant radiologist with experience in reporting HRCT imaging and a consultant respiratory physician with a major interest in bronchiectasis. A consensus score was produced by using the following criteria. Bronchiectasis was present when one or more of the criteria were fulfilled: (1) internal diameter of the bronchus greater than that of the adjacent pulmonary artery; and (2) a lack of tapering of the bronchial lumen toward the periphery.
In the derivation cohort, CT scans were scored independently, and a kappa coefficient was calculated.
Patients (Derivation and Validation Cohorts)
Patients were included if they had a clinical diagnosis of bronchiectasis with regular cough and sputum production, with or without recurrent chest infections, and cause of bronchiectasis was idiopathic or postinfective according to the British Thoracic Society guidelines. 10 Patients were excluded if they had an alpha 1 -antitrypsin deficiency, had a smoking history of > 5 pack-years, were a current smoker, or were an ex-smoker of < 1 year.
Scoring the CT Scans
The Bhalla and modified Reiff scores were calculated for all patients who met the inclusion and exclusion criteria. Both of these scores were jointly assessed by consensus by a chest physician and radiologist both blinded to the clinical status of the patient. The Bhalla score was calculated by scoring each of the nine categories and then adding up the total score. 6 The total points were then subtracted from 25 to obtain the Bhalla score. The maximum points that can be obtained in a Bhalla score is 22 (prior to subtracting from 25) (e- Table 1 ).
The modified Reiff score 7 used (0-18) was based on the number of lobes (maximum: 6, including the lingula) and the severity of bronchial dilatation compared with the adjacent vessel (0 ¼ no bronchiectasis; 1 ¼ 1-2 times; 2 ¼ 2-3 times; 3 ¼ > 3 times).
Subdivision of the CT Scores
The total range for the Bhalla score is from 3 to 25, with a lower score indicating more severe radiological bronchiectasis. This score was subdivided into mild (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) , moderate (9) (10) (11) (12) (13) (14) (15) , and severe (3) (4) (5) (6) (7) (8) .
The total range of the modified Reiff score is from 0 to 18. This score was subdivided into mild (1-6), moderate (7) (8) (9) (10) (11) (12) , and severe (13) (14) (15) (16) (17) (18) .
Bronchiectasis Radiologically Indexed CT Score
The Bronchiectasis Radiologically Indexed CT Score (BRICS) (detailed in the Results section) would be devised based on multivariable analysis of the Bhalla score and its ability in predicting clinical parameters of severity.
External Validation of the BRICS
The BRICS was externally validated by six centers across the United Kingdom and Europe by a chest physician and a radiologist. The score was validated in 50 consecutive individual patients from each center (except Dundee and London, where the score was validated in 60 and 42 patients, respectively). The protocols for imaging were similar to those at our center and were viewed in the respective PACS version available at various centers.
Sputum Neutrophil Elastase Activity
Sputum neutrophil elastase activity was measured when available in the derivation cohort. Sputum was ultracentrifuged at 50,000g for 90 min at 4 C. The colloidal solution phase was stored at -70 C until needed for analysis of the activity of free neutrophil elastase activity. We measured free elastase activity by spectrophotometry with a synthetic substrate (methoxysuccinyl-Ala-Ala-Pro-Val nitroanilide; Sigma).
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BSI and FACED Score
The BSI and the FACED 10 score were calculated on all patients in the derivation and validation cohorts (except in the London cohort). In the BSI score, a score between 0 and 4 indicated mild disease, 5 to 8 moderate disease, and $ 9 severe disease. In the FACED score, a score between 0 and 2 indicated mild disease, 3 to 4 moderate disease, and 5 to 7 severe disease.
Statistical Analysis
Statistical analysis was performed by using GraphPad PRISM, version 5 (GraphPad Software, Inc). Parametric and nonparametric data are presented as mean AE SEM and median (interquartile range).
Adjustment for potential confounders was achieved by using multivariable logistic regression. Multivariable regression models were constructed by including demographic (age, sex, co-morbidities, and smoking history) ( Table 1 ) and clinical (FEV 1 > 80% predicted, FEV 1 50%-80% predicted, FEV 1 < 50% predicted, colonization with Pseudomonas aeruginosa and/or enteric gram-negative organisms, colonization with other potential pathogenic organisms, sputum purulence, bronchiectasis exacerbations, and hospital admissions for bronchiectasis exacerbations) characteristics to assess independent clinical factors that predict a severe Bhalla score; the Bhalla score was the dependent variable. A logistic regression was then performed to assess independent factors from the Bhalla score that predicted clinical disease severity. Receiver-operating characteristic (ROC) analyses of all three scores (Bhalla, modified Reiff, and BRICS) to the clinical severity markers were performed. One-way ANOVA (with Bonferroni correction for multiple comparisons) was used to compare the mild, moderate, and severe subscores of the Bhalla score, the modified Reiff score, and the BRICS vs each of the severity parameters. A Mann-Whitney U test and c 2 analysis were conducted to compare the free neutrophil elastase activity in the derivation cohort.
A one-way ANOVA (with Bonferroni correction for multiple comparisons) and ROC analysis of the collated independent data was performed to validate BRICS externally.
Results
A total of 184 consecutive CT scans of patients with idiopathic or postinfective etiology were analyzed in the derivative cohort. Baseline characteristics of the study patients in all the cohorts, including the validation cohorts, are shown in Table 1 .
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Chronic colonization was defined as isolation of pathogenic organism at least two times when clinically stable in the year following CT scanning.
Intraclass Coefficient
The kappa coefficient between the chest physician and chest radiologist was 0.88 (95% CI: 0.82-0.94).
Clinical Severity Markers Associated With the Bhalla Score
In a logistic regression model, factors significantly associated with the Bhalla score were FEV 1 < 50% predicted, sputum purulence, and hospital admissions ( Table 2) .
Factors of the Bhalla Score Associated With Clinical Severity Parameters
The three clinical disease severity markers associated with the Bhalla score were FEV 1 < 50% predicted, sputum purulence, and hospital admissions ( Table 2) .
Of the nine components of the Bhalla score (e- Table 1) , only the degree of bronchial dilatation and number of bronchopulmonary segments with emphysema were independently associated with FEV 1 < 50% predicted, sputum purulence, and hospital admissions (Table 3) according to logistic regression analysis. Emphysema was diagnosed by assessing the lung parenchyma on lung windows and was classified as paraseptal, centrilobular, or panacinar based on accepted morphologic diagnostic criteria.
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Simplified Scoring System BRICS was developed by combining the parameters of bronchial dilatation and number of bronchopulmonary segments with emphysema, as these two components of the Bhalla score were significantly associated with clinical severity markers. The new score ranges from 0 to 5 (1 indicates mild disease, 2-3 indicates moderate disease, and > 3 indicates severe disease) ( Table 4) . 
BRICS Correlates With Clinical Disease Severity Markers
The Bhalla (P < .0001) and the BRICS (P ¼ .004) were significantly related to percent predicted FEV 1 . The modified Reiff score (P < .0001) and the BRICS (P ¼ .008) were significantly related to the sputum purulence. The Bhalla score (P ¼ .005) and the BRICS (P ¼ .0001) were significantly related to hospital admissions per year. The BRICS was significantly related to all three clinical disease severity markers (Fig 1) .
Free Neutrophil Elastase Activity
Sputum samples were available in 113 patients of the derivation cohort. Of these, 22 (19%) had emphysema on their CT scans, and 91 (81%) did not. The mean AE SEM elastase in the group that had emphysema on CT imaging was 60.6 AE 13.7 ng/mL; in the other group, it was 7.6 AE 1.6 ng/mL (P < .0001) (Fig 2) . Table 1 describes the baseline characteristics of the independent cohorts. The data from the independent cohorts were collated, and the BRICS was calculated. Cumulatively, percent predicted FEV 1 (P < .0001), sputum purulence (P ¼ .0007), and hospital admissions (P < .0001) were all significantly related to the BRICS (Fig 3) . The ROC curve value for percent predicted FEV 1 was 0.81; for sputum purulence, it was 0.70; and for hospital admissions, it was 0.70. The results were in similar in each validation center.
Validation of the BRICS in Independent Cohorts
BRICS Severity Compared With Severity of BSI and FACED
On combining data from both the derivation and validation cohorts, BRICS severity was calculated, and the corresponding BSI and FACED scores were tabulated. There was a significant association between the severity of the BRICS and the severity of the BSI and FACED score (P < .0001 for both scores) (Fig 4) .
Emphysema on CT Scan
Combining the data from all centers, emphysema was reported in 50% AE 15.6% of the cohort. Data on the type of emphysema was available from three centers (Belgium, Edinburgh, and London). A total of 48 scans with emphysema subtype were analyzed across these centers. Panacinar emphysema was present in 31 (64%), centrilobular in 9 (19%), and paraseptal in 8 (17%) of the cohort.
Discussion
This study is the first multicenter international trial to develop a radiological scoring system for use in idiopathic or postinfective bronchiectasis in a cohort with limited smoking history. In this study, we developed a simplified scoring system of CT scans in patients with bronchiectasis and found that this score was significantly associated with clinical parameters of disease severity. The BRICS was devised by using parameters of bronchial dilatation and number of bronchopulmonary segments with emphysema on HRCT scans of 184 patients in the derivation cohort; the patients had either idiopathic or postinfective bronchiectasis. The score ranges from 0 to 5 in this scoring system, with a higher score indicating increasing disease severity. The score was significantly associated with percent predicted FEV 1 , sputum purulence, and hospital admissions for bronchiectasis exacerbations. In addition, we found that free neutrophil elastase activity, an established marker of neutrophilic airway inflammation in bronchiectasis, 12, 16 was significantly higher in those patients who had emphysema according to their CT scans. The BRICS was compared with the existing Bhalla score and the modified Reiff score, and it was found to be as reliable and predictive of disease severity as these other scores. This score was then externally validated in a cohort of 302 patients across six centers in Europe. The results across these six centers were similar and in keeping with the derivation cohort.
To the best of our knowledge, this finding is the first simplified radiological score that has been developed to assess disease severity in patients with idiopathic and postinfective bronchiectasis.
The BSI and FACED score were not significantly associated with percent predicted FEV 1 , sputum purulence, and hospital admissions for bronchiectasis exacerbations; however, these two scores were not designed for the aforementioned end points. Hence, the BRICS is the first radiological severity score correlating with significantly with clinical parameters that can perform risk assessments for severity.
There are currently no markers to predict radiological disease severity in bronchiectasis. The clinical parameters of severity that were statistically significant in the multiple regression models have been shown to be of significance in previous studies. 8, 10, 11 It is well established that FEV 1 is an important functional marker of pulmonary disease. We have previously reported that sputum purulence is associated with disease severity in bronchiectasis. 11 It seems logical that if a patient requires repeated hospital admissions for bronchiectasis exacerbations as defined by the British Thoracic Society guidelines, 10 it indicates that the patient has more severe disease. In addition, in the BSI, the authors have shown that previous hospital admissions and FEV 1 < 30% predicted are independent predictors of hospital admissions and mortality in bronchiectasis. 8 In the present study, we were able to show that the new simplified BRICS can predict disease severity based on radiological appearances alone. In addition, subdivisions of the BRICS illustrated that an increasing score is chestjournal.org associated with increasing disease severity. Patients with a higher score on the BRICS had lower FEV 1 , more purulent sputum, and increased hospital admissions for bronchiectasis exacerbations. Validation of the BRICS internationally showed that this tool was a simple but robust scoring system that can be used in day-to-day clinical practice.
Free neutrophil elastase activity was significantly higher in patients with emphysema on CT imaging in the derivation cohort. This outcome is in keeping with data published in the literature. 12, 16 Loubeyre et al 13 has
shown that there was a high prevalence of emphysema in bronchiectasis. Activation of matrix metalloproteinase by free neutrophil elastase activity has been shown to be one of the mechanisms of driving structural lung damage in early cystic fibrosis. 14 There is evidence to support that unopposed neutrophil elastase activity has come to be implicated in the pathobiology of many lung diseases, particularly in chronic obstructive lung disease. Neutrophil elastase activity is known for its matrixdegrading capacity and broad substrate repertoire; there is evidence to hypothesize that enhanced neutrophil elastase activity predominance over its natural inhibitors may result in, or at perhaps intensify, pathologic states such as fibrosis and emphysema. 17 The two components defining the BRICS have been used in earlier studies. Bronchial dilatation is the classic radiological feature, which defines bronchiectasis on CT scans. Although bronchial dilatation is associated with asthma, chronic bronchitis, and pulmonary fibrosis, we can safely confirm that because our study was conducted in a well-defined cohort of patients with either idiopathic or postinfective bronchiectasis, (ie, the two most common causes of bronchiectasis 18 ), bronchial dilatation represented bronchiectasis. Loubeyre et al 13 described emphysema in the CT scans of 90 consecutive patients with bronchiectasis and concluded that there was a high prevalence of emphysema in patients with bronchiectasis.
HRCT imaging is a sensitive, noninvasive technique for demonstrating bronchiectasis. The need for the creation of scoring systems originates from the fact that CT scanning as a test depicts structural abnormalities in great detail but is a qualitative image, and the extent of the abnormality has to be quantified as a score to be used in statistical analysis. 19 Association studies between CT scans and clinical parameters (mostly lung physiology) have been conducted previously. 20, 21 These studies have used the Bhalla score, the modified Reiff score, or a simplified score that the investigators have agreed on by consensus. Airflow limitation can be seen in more advanced bronchiectasis. 22, 23 Studies have
shown that airflow obstruction in bronchiectasis is linked to evidence of structural abnormality on CT scans. 9, 21, 24 The BRICS and our study findings corroborated this finding.
To the best of our knowledge, the present study is the first international multicenter, simplified scoring system designed for use in idiopathic or postinfective bronchiectasis. This system is a useful clinical tool to assess radiological and clinical severity in bronchiectasis. This study is not confounded by other etiologies of bronchiectasis and pertains to a cohort with limited smoking history. The significantly higher levels of neutrophil elastase activity in the cohort with emphysema on the CT scans compared with those with no emphysema suggest that elastase is perhaps one of the possible causes for emphysema in this group. There was a significant association between the BRICS and the BSI and FACED score. The BRICS may be used to follow up patients longitudinally and hence be a useful research tool for future studies. In addition, radiological scores could be used as an adjunct to clinical assessment in categorizing patients into disease severity groups, which could then guide management.
The present study did have some limitations. It was conducted in a cohort in which the patients had idiopathic or postinfective bronchiectasis. Bronchiectasis due to other etiologies thus requires further study.
Conclusions
We developed and validated a simplified CT scoring system based on degree of bronchial dilatation and number of bronchopulmonary segments with emphysema in patients with idiopathic and postinfective bronchiectasis, with limited smoking history.
